欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	FR/H/0554/003
药品名称	BABIVEN G15
活性成分	acetylcysteine 0.31 g/l alanine 1.45 g/l arginine 0.94 g/l aspartic acid 0.94 g/l calcium gluconate 2.69 g/l chromium(III)chloride 0.1 mg/l copper sulfate 1.18 mg/l ferrous sulphate 2.49 mg/l glucose monohydrate 165.0 g/l glutamic acid 1.63 g/l glycine 0.48 g/l histidine 0.48 g/l isoleucine 0.71 g/l leucine 1.61 g/l lysine monohydrate 1.45 g/l magnesium lactate 0.95 g/l manganese(II)chloride tetrahydrate 0.36 mg/l methionine 0.3 g/l phenylalanine 0.62 g/l potassium dipotassium phosphate 1.39 g/l potassium iodide 0.07 mg/l potassium chloride 0.67 g/l proline 1.29 g/l serine 0.87 g/l sodium fluoride 1.11 mg/l sodium chloride 1.75 g/l taurine 0.07 g/l threonine 0.83 g/l tryptophan 0.32 g/l tyrosine 0.11 g/l valine 0.83 g/l zinc acetate 6.72 mg/l
剂型	Solution for infusion
上市许可持有人	Fresenius Kabi France
参考成员国 - 产品名称	France (FR)
互认成员国 - 产品名称	Belgium (BE) Kidiamix Netherlands (NL) Austria (AT) Pediaven Glucose 15% Infusionslösung Spain (ES) Portugal (PT) Italy (IT) Poland (PL) Latvia (LV) Lithuania (LT) Pediaven G15 infuzinis tirpalas Estonia (EE) PEDIAVEN G15 Hungary (HU)
许可日期	2014/05/05
最近更新日期	2020/01/21
药物ATC编码	B05BA10 combinations
申请类型	TypeLevel1：Known Active Substance TypeLevel2：Initial Application TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载
市场状态	Positive